Titan Biotech Liabilities 2024

Liabilities Details

Assessing Titan Biotech's Liabilities

Titan Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Titan Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Titan Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Titan Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Titan Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Titan Biotech Stock

What is the level of liabilities of Titan Biotech this year?

Titan Biotech has a debt balance of 246.04 M INR this year.

What were the liabilities of Titan Biotech compared to the previous year?

The liabilities of Titan Biotech have increased by 12.62% increased compared to the previous year.

What are the consequences of high debt for investors of Titan Biotech?

High liabilities can pose a risk for investors of Titan Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Titan Biotech?

Low liabilities mean that Titan Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Titan Biotech affect the company?

An increase in liabilities of Titan Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Titan Biotech affect the company?

A decrease in the liabilities of Titan Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Titan Biotech?

Some factors that can influence the liabilities of Titan Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Titan Biotech so important for investors?

The liabilities of Titan Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Titan Biotech take to modify the liabilities?

To change its liabilities, Titan Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Titan Biotech pay?

Over the past 12 months, Titan Biotech paid a dividend of 1.8 INR . This corresponds to a dividend yield of about 0.36 %. For the coming 12 months, Titan Biotech is expected to pay a dividend of 1.8 INR.

What is the dividend yield of Titan Biotech?

The current dividend yield of Titan Biotech is 0.36 %.

When does Titan Biotech pay dividends?

Titan Biotech pays a quarterly dividend. This is distributed in the months of October, October, October, October.

How secure is the dividend of Titan Biotech?

Titan Biotech paid dividends every year for the past 4 years.

What is the dividend of Titan Biotech?

For the upcoming 12 months, dividends amounting to 1.8 INR are expected. This corresponds to a dividend yield of 0.36 %.

In which sector is Titan Biotech located?

Titan Biotech is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Titan Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Titan Biotech from 10/29/2023 amounting to 1.8 INR, you needed to have the stock in your portfolio before the ex-date on 9/22/2023.

When did Titan Biotech pay the last dividend?

The last dividend was paid out on 10/29/2023.

What was the dividend of Titan Biotech in the year 2023?

In the year 2023, Titan Biotech distributed 1.5 INR as dividends.

In which currency does Titan Biotech pay out the dividend?

The dividends of Titan Biotech are distributed in INR.